Vietnam’s homegrown COVID-19 vaccine candidate 52% effective against symptomatic conditions
It offers 92 percent protection against severe conditions and 100 percent protection against death
It offers 92 percent protection against severe conditions and 100 percent protection against death
The third phase of human trials of the Covivac vaccine has been put on hold
HLB Company has signed an MoU with Nanogen Pharmaceutical Biotechnology JSC regarding the supply of Nano Covax
The premier tasked relevant ministries with facilitating the process of vaccine research, technology transfer, and production
Covivac is expected to be distributed to the local market within the first quarter of 2022
Nanocovax, one of Vietnam’s homegrown COVID-19 vaccines, is expected to be available by the fourth quarter of this year
This is the first vaccine made in Vietnam to have been tested on humans
Four Vietnamese candidates are each running their own race towards an approved COVID-19 vaccine